Connect
At the end of July, the Alzheimer’s Association hosted its annual International Conference (AAIC) in Toronto, Canada. Throughout the week, the results of several major on studies were released. Here are a few key studies that were announced:
- U.S. POINTER Study: The Pointer was a two-year, randomized control trial that tested two lifestyle interventions in a large group of older adults at risk for cognitive decline. The interventions covered physical activity, nutrition, and cognitive and social challenges but different in the level of structure, accountability, and support provided.
- The study found that cognitive function improved in both groups but the one that received more structured support showed the most benefit, nearly two years of protection against age-related cognitive decline. These benefits were consistent across age, sex, ethnicity, heart health status, and APOE genetic risk.
- Combination of Heart Health Drugs: An observational study of more than 4,500 older adults found that taking a combination of common drugs to treat blood pressure, cholesterol, and diabetes slows cognitive decline. While this study shows promising results, clinical trials are needed to definitively prove they could slow cognitive decline. A full write up of this study is available on BeingPatient.
For a full write up of the week, visit this press release from the Alzheimer’s Association. It provides an overview of each study and a link to its respective press release.
Like
Helpful
Hug
Connect